| drug name | Mometasone Furoate |
| classification | Corticosteroid, Topical |
| pharmacokinetics | | absorption | Topical application results in limited systemic absorption. Absorption primarily depends on the vehicle and area of application. | | distribution | Distributed primarily to the skin. | | metabolism | Metabolized in the liver. | | excretion | Excreted primarily in the urine and feces. |
|
| suggested dosage | | note | Dosage is highly dependent on the specific condition and the formulation. This information is for illustrative purposes only and should not be used for self-treatment. Consult a healthcare professional. | | examples | | 1 | | condition | Atopic Dermatitis | | dosage | Apply a thin film once daily to affected areas. |
| | 2 | | condition | Contact Dermatitis | | dosage | Apply a thin film once daily to affected areas. |
| | 3 | | condition | Other skin conditions | | dosage | Consult a physician. |
|
|
|
| indications | | 1 | Treatment of inflammatory skin conditions such as atopic dermatitis, contact dermatitis, and other inflammatory skin disorders. | | 2 | Treatment of skin conditions involving pruritus (itching). |
|
| safety in pregnancy | | category | Category C (limited or no adequate studies in pregnant women). Potential risks to the fetus may exist. Discretion should be used. | | recommendation | Use only when clearly indicated and under direct supervision of a healthcare professional. |
|
| safety in breastfeeding | | recommendation | Limited data available. Potentially transferrable to breast milk. Consult a healthcare professional before use. |
|
| side effects | | 1 | Local skin reactions (e.g., irritation, burning, stinging, redness, dryness, or rash) | | 2 | Systemic effects are uncommon at topical doses due to limited absorption. However, potential systemic effects include adrenal suppression (rare). | | 3 | Increased risk of infection (especially fungal infection) at the site of application if applied improperly. |
|
| alternatives | |
| contraindications | | 1 | Known hypersensitivity or allergy to mometasone furoate or other ingredients in the formulation. | | 2 | Infections in the area of application that are not properly managed (may worsen the condition). | | 3 | Use in large areas of the body, prolonged use or high doses. |
|
| interactions | | note | Limited information on interactions exists. Always inform your healthcare professional about all medications being used. | | potential interactions | | 1 | Potentially interacting with other topical corticosteroids or immunosuppressants. |
|
|
| warnings and precautions | | 1 | Avoid contact with eyes. | | 2 | Do not use on broken skin. | | 3 | Stop use and consult a physician if condition worsens or does not improve. | | 4 | Monitor for signs of skin infections during therapy. | | 5 | Use the lowest effective dosage for the shortest duration of treatment. |
|
| additional information | | application methods | Apply a thin film to the affected area as directed. Do not rub into skin. Wash hands after application. | | storage | Store at room temperature, protect from light and moisture. |
|
| patient specific considerations | | age | 25 years – No specific dosage adjustments are usually necessary. | | weight | 70 kg - No specific dosage adjustments are usually necessary. | | general note | Individual responses to medications vary. Always follow the directions and advice of your healthcare provider. |
|
